翰森製藥(03692.HK)抗腫瘤產品獲藥品註冊證書

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

翰森製藥(03692.HK)抗腫瘤產品獲藥品註冊證書

阿思達克 07-04 23:59

翰森製藥(03692.HK)公布，附屬江蘇豪森開發的Palbociclib Capsules獲得中國國家藥品監督管理局頒發藥品註冊證書。該產品為抗腫瘤藥物，適用於激素受體陽性、人表皮生長因子受體2陰性的局部晚期或轉移性乳腺癌，應與芳香化(酉每)抑制劑聯合使用作為絕經後女性患者的初始內分泌治療。

翰森製藥(03692.HK)

Relevant Stocks

翰森製藥(03692.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

翰森製藥(03692.HK)抗腫瘤產品獲藥品註冊證書

Services

About Us

Agreement Statement